Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
EXAS
EXAS
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
EXAS News
EHR-Enabled Colorectal Cancer Screening Achieves Significant Impact
6d ago
Newsfilter
Dividend Stocks Surge Amid Market Volatility, Outperforming S&P 500
Mar 02 2026
CNBC
Following Grail's Study Setback, What Remains for Cancer Blood Screening?
Feb 26 2026
Barron's
Abbott Laboratories' $23 Billion Acquisition of Exact Sciences Enhances Growth Potential
Feb 25 2026
Fool
Abbott Labs Increases Dividends for 54 Years, Acquires Exact Sciences
Feb 25 2026
NASDAQ.COM
Abbott Laboratories Plans $20B Bond Sale for Exact Sciences Acquisition
Feb 23 2026
seekingalpha
Exact Sciences Shareholders Approve Abbott Acquisition
Feb 20 2026
seekingalpha
Exact Sciences Shareholders Greenlight Abbott Acquisition
Feb 20 2026
moomoo
Exact Sciences Reports Significant Revenue Growth in Q4
Feb 13 2026
NASDAQ.COM
Exact Sciences Reports Q4 Pretax Loss of $85.083 Million
Feb 13 2026
moomoo
Exact Sciences Reports Q4 Operating Loss of $82.595 Million
Feb 13 2026
moomoo
Exact Sciences Reports Q4 Revenue of $878.381 Million, Exceeding IBES Estimate of $860.9 Million
Feb 13 2026
moomoo
Abbott Laboratories: A Steady Dividend Growth King
Feb 12 2026
Fool
Investor Rights Law Firm Investigates Multiple Companies
Feb 09 2026
Globenewswire
Monteverde Law Firm Investigates Multiple Mergers
Feb 09 2026
Globenewswire
3 Strategies to Calm Stock Market Anxiety Ahead of Key Jobs Report
Feb 09 2026
Barron's
Show More News
